ReviewFrontiers in medicine2025
Recent trends in gene-targeted therapies and their influence on surgical decision-making in rheumatoid arthritis affecting the hands, feet, and ankles.
Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis (RA) is an autoimmune disorder associated with chronic inflammation, progressive deformities of the joints, and limited mobility, especially in the hands, feet, and ankles. Recent discoveries in molecular genetics and immunotherapeutic approaches have enhanced the development of more effective RA medications. Gene-targeted therapy facilitates an accurate regulation of the immune system, ultimately preventing the destruction of joints. The new interventions that prevent the progression of the disease require orthopedic surgeons to reconsider the time and method of conducting surgery. This article discusses the latest developments in the field of gene-targeted therapy and their influence on the decision-making process in surgery. There has been a current change in clinical practice to involve early and preventive interventions for joint pathology to delay the use of surgery until it is unavoidable. These innovative techniques are based on the use of focused medicine and foster interdisciplinary cooperation of experts in orthopedics and rheumatology, which, in turn, increases the mobility of the patient and the overall quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.